BI-730357

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameBI-730357
Drug Alias NameBI-730357
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma-t antagonists
TargetsNuclear receptor ROR-gamma-t
Therapy Area/IndicationsPlaque psoriasisPsoriasisArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim (China) Investment Co Ltd
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. KgBoehringer Ingelheim Pharma Gmbh & Co KgBoehringer Ingelheim International Gmbh
Active IndicationsPlaque psoriasis
Inactive IndicationsPsoriasisArthritis, Psoriatic

Other Information

ATC CodeN/A
Related LinksN/A